From a distance, on a clear morning, the Novartis Campus almost resembles a city of its own. Trees are reflected in bright glass facades, people sit beneath arcades enjoying coffee, bicycles glide silently across the granite pavement, and here and there the view opens toward the Rhine. Anyone walking along Fabrikstrasse today encounters an architecture of calm and concentration. At first glance, nothing recalls the time when steam boilers thundered here, freight trains shunted across the site and ships unloaded coal, chemicals, and dyes. And yet this is precisely what makes the place unique: the Campus was not built on an empty greenfield site. It is the result of a transformation. For more than a century, people worked, produced, experimented, and built on the St. Johann site. The history of today’s Novartis Campus is therefore not merely the story of a modern research location. It is also the story of Basel’s industry, chemistry, pharmaceutical research and, ultimately, the changing nature of work in the twenty-first century. When Novartis decided in the early 2000s to completely rethink the site, the project involved far more than constructing new buildings. The company wanted to create a place that would foster research, attract talent from around the world, and encourage collaboration. Architecture was not meant to be scenery, but a tool. Italian architect and urban planner Vittorio Magnago Lampugnani was commissioned to develop the masterplan. What emerged is today one of the most unusual corporate campuses in Europe. Unlike many corporate headquarters in the United States or Asia, the Campus was not conceived as a secluded island. Instead, it consciously integrates itself into the city of Basel and reinterprets classical urban principles: streets, squares, parks, arcades, and meeting spaces form a dense network connecting science, work, and everyday life.
As a place for encounter, the Campus offers a wide range of opportunities for relaxation and personal interaction outside the usual office setting.
The Campus also tells the story of Basel itself – a city that understood early on that innovation does not emerge from isolation, but from networks, exchange, and the courage for transformation. St. Johann was once a place of production. Today it is a place of knowledge. Yet the industrial past has not disappeared. It still resonates – in the geometry of the site, in individual buildings, in street names, and, not least, in the mentality of a company whose roots lie in the dye chemistry of the nineteenth century. The birth of an industrial site The history of the St. Johann site begins not with medicines, but with colors – more precisely, with a scientific breakthrough that transformed Europe in the second half of the nineteenth century. In 1865, British chemists succeeded for the first time in producing synthetic aniline dyes. What initially appeared to be a technical curiosity quickly developed into an industrial boom. The new dyes were cheaper, more stable and more intense than natural pigments. Within just a few years, an entirely new industry emerged, first dominating England and later spreading to Germany, France, and Switzerland. Basel quickly proved to be an ideal location for this development. The city’s position along the Rhine provided excellent transportation links and commercial connections throughout Europe, while access to highly trained chemists and a strong regional textile industry created ideal conditions for the growing dye business.
In 1886, Alfred Kern and Edouard Sandoz founded the “Chemische Fabrik Kern & Sandoz” on the St. Johann site. The beginnings were modest. A few production facilities, a boiler house, a laboratory, and a steam engine formed the core of the company. But demand for synthetic dyes was enormous. At the time, the site smelled of coal, acids, and solvents. Steam whistles defined the rhythm of the day. Trucks and freight wagons transported raw materials and finished products. The factory operated like an industrial machine. Yet even in these early years, Sandoz began looking beyond dye chemistry alone. From dyes to medicine The transition from dye chemistry to pharmaceutical research was no coincidence. Many of the chemical processes developed for dye manufacturing could also be applied to medical products. The boundaries between chemistry and pharmacy were fluid. During the First World War, Sandoz decided to establish its own research department, a decision that would shape the company’s future. A key role was played by Arthur Stoll, an ETH scientist who joined Sandoz on the recommendation of board member Robert Gnehm. Stoll succeeded in isolating therapeutically useful substances from ergot alkaloids. His drug Gynergen became a major success. With this achievement, the pharmaceutical era of the company began.
Over the following decades, research expanded steadily. New laboratory buildings were constructed, chemists and biologists increasingly worked together across disciplines, and medicines became ever more important to the company’s identity. One of the most fascinating figures of this period was Albert Hofmann. Hired by Arthur Stoll, the chemist also experimented with ergot compounds and accidentally discovered the hallucinogenic effects of LSD. During the 1950s and 1960s, St. Johann increasingly evolved into a modern research and production site. Pharmaceutical activities steadily overtook classical chemistry in importance.
The park along the Rhine, with its unique view of the city, is an inviting place to relax.
New office buildings and high-rises appeared. The site became denser and technologically more sophisticated. What had once been a collection of industrial structures gradually developed into a complex industrial network. At the same time, the company’s self-image changed. Research increasingly became its strategic core.
Boom years and industrial density The postwar decades brought economic growth. Basel developed into one of Europe’s most important centers for the chemical and pharmaceutical industries. Construction, expansion and modernization transformed the St. Johann site. Investments rose dramatically. New laboratories, administrative buildings, and production facilities emerged one after another. The striking 503 high-rise was built, as was the staff restaurant later known as the Foodtower.
The Port of St. Johann played a central role during this period. Raw materials from around the world arrived in Basel via the Rhine. Ships transported grain, coal, chemicals, and industrial goods. The district was noisy, busy, and dominated by heavy traffic. At the same time, Basel developed into an international center of science. Universities, hospitals, and companies worked increasingly closely together. Research became global. Yet the industrial boom also had its darker side. The site was organized efficiently, but it was hardly designed for people. Between production halls, warehouses and office buildings, there was little room for quality of life. Green spaces were rare and the architecture was overwhelmingly utilitarian. St. Johann was a place for work, not for encounter.
Frank Gehry’s whimsical building, which breaks away from the Campus’s strict grid, embodies creativity, innovation, and international appeal.
The crisis of industrial society The oil crisis of the 1970s shook the industrial logic of many European sites. Globalization, rising competitive pressure and the relocation of chemical production to Asia fundamentally changed the economic landscape. Sandoz and Ciba-Geigy also felt these changes. Traditional dye production steadily lost importance. Specialty chemicals came under increasing price pressure, while research and innovation became ever more crucial. As a consequence of these developments, Sandoz and Ciba-Geigy merged in 1996 to form Novartis. The merger marked a turning point. The new company wanted to focus entirely on life sciences – on medicines, research, and medical innovation. The old industrial site no longer fit this vision. Modern laboratories stood beside outdated production halls. Storage areas alternated with office buildings from different decades. St. Johann resembled a patchwork without a coherent concept. The idea of a campus In the early 2000s, Novartis therefore took a radical step: The entire site would be reimagined. The word campus was deliberately chosen. It stood for openness, knowledge, exchange, and international networking. At the same time, Novartis did not want to create a closed corporate park modeled on American examples. The new location was meant to be urban. Vittorio Magnago Lampugnani was commissioned to develop the masterplan, an architect and urban planner deeply engaged with European urban history and culture. For Lampugnani, the project was not simply architectural. It revolved around the question of how people work, communicate, and become creative. His goal was to create a place that fostered science without feeling sterile. Lampugnani’s vision Lampugnani did not look to futuristic technology cities for inspiration, but rather to historical European urban models. He was especially fascinated by the pre-industrial city: compact, mixed, pedestrian-friendly, and shaped by public spaces.
Fabrikstrasse is not only the Campus’s main thoroughfare. In a sense, the street also connects the future with the past.
For Lampugnani, creativity did not emerge solely inside laboratories. Innovation required encounters, coincidence, and exchange. He therefore placed people at the center of the masterplan. Fabrikstrasse became the central axis of the Campus. Side streets branch off from it at right angles, much like a classical city grid. Squares, arcades, cafés, and parks form nodes of communication. At the same time, Lampugnani developed a strict set of rules that gave the Campus a coherent identity despite the involvement of numerous international architects. One of the most important requirements was the maximum cornice height of 22 meters, based on the historic Forum 1 administrative building. This height restriction prevents monumental dominance and ensures that light, air, and human scale are preserved. At the same time, Lampugnani developed a grid that incorporated and reinterpreted the site’s industrial structures. The masterplan, however, was never intended as a rigid framework. On the contrary, individuality was explicitly encouraged. Lampugnani once remarked that the cities we love are shaped by many different hands. That, too, was meant to apply to the Campus. Architecture as dialogue One of the most remarkable aspects of the Campus is the diversity of its architecture. International architects such as Frank Gehry, Tadao Ando, David Chipperfield, Herzog & de Meuron, and SANAA designed buildings with distinct identities and architectural languages. And yet they never appear arbitrary.
This coherence stems from the strength of the masterplan. The buildings enter into dialogue with one another. They respect shared rules while interpreting them individually. The result is not a monotonous corporate park, but an urban fabric. The Campus functions less like a traditional corporate site and more like a city district. Fabrikstrasse as the backbone Anyone walking along Fabrikstrasse today moves along the site’s historical axis. The street already existed during the industrial era, and Lampugnani deliberately retained it as an identity-defining element linking past and present. Laboratories, offices, restaurants, artworks, and meeting spaces line the street.
The street signage is elegantly and unobtrusively embedded in the ground.
Arcades create transitions between inside and outside. Rows of trees structure the space. The design feels controlled, yet never sterile. Even details such as lighting, paving, and typography were carefully developed. The custom-designed Campus Font by Basel typographer Albert Maag forms part of this identity, alongside the granite paving stones and the street signs embedded into the ground. Together, these elements contribute to the distinct atmosphere of the place. Design as an attitude The Campus was not created through architecture alone. Graphic design, landscape architecture, lighting design, and art were equally important. Novartis commissioned some of the most renowned designers of their time. Landscape architect Peter Walker designed the green spaces, British designer Alan Fletcher created the visual identity, and Harald Szeemann developed the concept for art in public spaces. Together, they created a design culture extending far beyond conventional corporate design. The role of art Art on the Campus does not serve a decorative purpose. It is an integral part of the overall concept. Harald Szeemann understood art as a way of rhythmically interrupting spaces, creating moments of irritation, and opening new perspectives. Richard Serra’s monumental steel sculpture Dirk’s Pod marks the end of Fabrikstrasse like an urban anchor point. Other works are more subtle. Eva Schlegel’s Walkway, for example, connects architecture and perception, while Ulrich Rückriem’s stone sculptures invite contemplation. The art is not intended simply to please. It is meant to provoke thought.
Art blends seamlessly into the Campus experience, as seen in Eva Schlegel’s “Walkway.”
Research as a social practice The Campus is not a museum. Above all, it is a place of work. And this is where the project reveals its true radicalism. Novartis wanted to create working environments that actively encourage collaboration. Traditional individual offices and isolated laboratories were increasingly replaced by open structures. Atriums, meeting zones, cafés, and flexible workspaces enable spontaneous interaction. Biochemist Gottfried Schatz once described the Campus as an “oversized reaction vessel” in which people and ideas are meant to encounter one another as often as possible. The metaphor captures the essence perfectly. Innovation rarely emerges in isolation today. The development of modern medicines requires networks of biologists, chemists, data scientists, physicians, and engineers. The Campus attempts to support this collaboration spatially.
Thanks for reading Live.Magazine
Stay connected by subscribing to our newsletter
SubscribeBy submitting your email, you consent to Novartis AG collecting and processing your email data for Novartis internal use, in accordance with our privacy policy, and by protected technical means.
